Skip to main content
. Author manuscript; available in PMC: 2021 Jul 20.
Published in final edited form as: Vaccine. 2020 Jun 5;38(31):4820–4828. doi: 10.1016/j.vaccine.2020.05.057

Table 2. Model estimated parameters for each study site.

The symbols used in this table are explained in Table 1. Values in parentheses are 95% confidence intervals based on the profile likelihood. An example of the profile likelihoods for Model D in Kumasi is provided in Fig. S2.

Parameter R0 ωm
months
b1 Φ1
months
b2 Φ2
months
h d3 sc ωv
months
BIC
Accra
Model A 37.861
(36.22–39.54)
4.838
(4.46–5.23)
0.077 7.203 0.132 1.037 0.107 9.54E-06 0.989
(0.87–1.0)
1473.093
Model B 37.861
(36.22–39.54)
4.838
(4.46–5.23)
0.077 7.203 0.132 1.037 0.107 9.54E-06 0.989
(0.71–1.0)
24.102
(11.11–48.38)
1467.183
Model C 35.69
(34.24–37.52)
4.276
(3.72–4.68)
0.068 7.185 0.126 1.042 0.099 2.92E-05 0.987
(0.82–1.0)
1471.098
Model D 38.815
(37.35–40.36)
4.848
(4.32–5.29)
0.073 7.205 0.121 1.545 0.1 3.11E-05 0.961
(0.87–1.0)
26.342
(15.94–52.92)
1466.643
Kumasi
Model A 33.661
(29.5–36.2)
4.714
(3.46–5.75)
0.167 4.127 0.498 1.055 0.017 3.09E-07 0.734
(0.35–0.96)
656.518
Model B 33.661
(29.5–36.2)
4.714
(3.46–5.75)
0.167 4.127 0.498 1.055 0.017 3.09E-07 0.649
(0.42–0.88)
5.33
(1.23–14.29)
657.557
Model C 36.951
(33.2–40.4)
5.706
(4.56–6.72)
0.143 4.012 0.376 1.101 0.016 1.75E-07 0.81
(0.49–1.0)
615.916
Model D 38.589
(36.0-41.75)
5.989
(4.89–6.9)
0.144 4.034 0.373 1.104 0.016 1.88E-07 0.733
(0.38–0.93)
4.591
(1.4–10)
617.498
Navrongo
Model A 31.529
(30.36–32.78)
1.890
(0.39–3.18)
0.999 1.050 6.63E-08 5.125 0.012 2.54E-05 0.243
(0.08–0.36)
585.837
Model B 31.529
(30.36–32.78)
1.890
(0.39–3.18)
0.999 1.050 6.63E-08 5.125 0.012 2.54E-05 0.203
(0.08–0.32)
5.26
(2.46–8.4)
585.266
Model C 30.91
(29.87–31.71)
3.565
(2.64–4.44)
0.999 1.044 1.92E-08 4.755 0.013 3.46E-05 0.177
(0.10–0.37)
576.391
Model D 31.348
(30.48–32.18)
3.554
(2.71–4.53)
0.999 1.045 4.2E-08 3.574 0.013 2.23E-05 0.18
(0.04–0.32)
6.281
(2.7–11.76)
575.599